Vaxart, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92243A2006
USD
0.72
0.04 (5.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Vaxart, Inc.
Prelude Therapeutics, Inc.
TScan Therapeutics, Inc.
Trevi Therapeutics, Inc.
Design Therapeutics, Inc.
Vor Biopharma, Inc.
Greenwich LifeSciences, Inc.
Galectin Therapeutics, Inc.
XBiotech, Inc.
INmune Bio, Inc.
BioVie, Inc.

Why is Vaxart, Inc. ?

1
With a growth in Net Sales of 43.95%, the company declared Outstanding results in Sep 25
  • The company has declared positive results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD -30.28 MM
  • NET SALES(Q) Highest at USD 72.41 MM
  • OPERATING PROFIT MARGIN(Q) Highest at -7.91 %
2
With ROE of -189.50%, it has a attractive valuation with a 6.11 Price to Book Value
  • Over the past year, while the stock has generated a return of 10.88%, its profits have risen by 29.9%
3
High Institutional Holdings at 20.91%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Vaxart, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Vaxart, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Vaxart, Inc.
25.13%
-0.17
115.36%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
81.09%
EBIT Growth (5y)
-192.03%
EBIT to Interest (avg)
-47.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.84
Tax Ratio
0.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.91%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.11
EV to EBIT
-2.91
EV to EBITDA
-3.35
EV to Capital Employed
27.00
EV to Sales
0.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-928.54%
ROE (Latest)
-189.50%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

31What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -30.28 MM

NET SALES(Q)

Highest at USD 72.41 MM

OPERATING PROFIT MARGIN(Q)

Highest at -7.91 %

RAW MATERIAL COST(Y)

Fallen by -25.33% (YoY

OPERATING PROFIT(Q)

Highest at USD -5.73 MM

PRE-TAX PROFIT(Q)

Highest at USD -8.12 MM

NET PROFIT(Q)

Highest at USD -8.14 MM

EPS(Q)

Highest at USD -0.04

-2What is not working for the Company
CASH AND EQV(HY)

Lowest at USD 55.06 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.3 times

Here's what is working for Vaxart, Inc.

Net Sales
At USD 72.41 MM has Grown at 258.82%
over average net sales of the previous four periods of USD 20.18 MM
MOJO Watch
Near term sales trend is extremely positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -30.28 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 72.41 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Profit Margin
Highest at -7.91 % and Grown
In each period in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Operating Profit
Highest at USD -5.73 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -8.12 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -8.12 MM has Grown at 42.31%
over average net sales of the previous four periods of USD -14.08 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -8.14 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD -8.14 MM has Grown at 42.51%
over average net sales of the previous four periods of USD -14.16 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.04
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -25.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Vaxart, Inc.

Cash and Eqv
Lowest at USD 55.06 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio
Lowest at 3.3 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio